Part 34: Patrizia Paterlini-Bréchot, MD

Dr. Patrizia Paterlini-Bréchot is a tenured Professor of Cell and Molecular Biology and Oncology at Paris Descartes University and head of a research team at the French National Institute of Health and Medical Research (INSERM). She studied medicine at the University of Modena and Reggio Emilia, where she specialized in hematology and oncology. In 1988 she turned her focus on research in cell and molecular biology and published over 80 research articles and reviews in national and international scientific journals. She received numerous awards and honors including Best thesis in Medicine (1978), the Best research in Hematology (1979), Assistance Publique/Hôpitaux de Paris (1995, 2002), Technological development (2007), and European Inventor Award Finalist (2019). She is listed as an inventor on over 5 patents. The most significant outcome of Dr. Paterlini’s research work is the invention and development of ISET (Isolation by Size of Epithelial tumor / trophoblastic cells) for predictive oncology and noninvasive prenatal diagnosis. She is the founder/co-founder of two biotechnological innovation startups: Metagenex SA (2001) and Rarecells SAS (2009). She is also a Cheif Scientific Officer (CSO) of Rarecells. Her invention of the ISET® technology for isolation of the very rare Circulating Tumor Cells (CTC) from blood, allowing their diagnostic identification by cytopathology and their molecular characterization, promises to improve the span and quality of life of patients with cancer. https://www.lady-first.me/article/patrizia-paterlini-br-chot-the-woman-who-could-save-us-from-cancer,4382.html. Read more …